Hardware & electrical equipment
Amphion Innovations agrees loan facility top up
Following drawdown of the new funds, the balance on the loan facility will be US$4.23mln
Company
Polarean Imaging PLC
LON:POLX
Polarean Imaging PLC and its wholly owned subsidiary, Polarean Inc., are revenue-generating, medical imaging technology companies operating in the high-resolution medical imaging space. Polarean aspires to revolutionize pulmonary medicine by bringing the power and safety of MRI to the respiratory healthcare community in need of new solutions to evaluate lung function, diagnose disease, characterize disease progression, and monitor response to treatment.
177 stories · page 9 of 9
Hardware & electrical equipment
Amphion Innovations lines up FireStar for 2019 IPO
Another of Amphion’s investee companies, Polarean Imaging, was floated on AIM earlier this year, and FireStar is the next one earmarked to go public
Hardware & electrical equipment
Amphion Innovations announces first patient enrolment in Phase III FDA clinical trial
The trial is aiming to demonstrate the non-inferiority (i.e. the efficacy in treatment) of the group's drug-device combination
Amphion Innovations gets a boost from Polarean's progress
Some of the main news-driven risers and fallers in London on Thursday...
Amphion mulls change in focus to late-state pre-IPO opportunities
The timing and ability of the group to realise its investments in partner companies is subject to inherent uncertainty due to numerous factors. The company is looking to change its business model a bit to become a financial supporter of com
Hardware & electrical equipment
Amphion Innovations chairman and non-executive director step down
The AIM-listed medical, life science and tech business developer said it had begun the process of seeking suitable candidates
Archive
Proactive news snapshot: C4X Discovery, Hurricane Energy, Alba Mineral Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
FTSE 100 closes higher ending an "ugly quarter"; GKN top riser after Melrose succeeds in bid
Turnaround group Melrose received valid acceptances for its offer for GKN representing around 52.43% of the voting rights